- Home
- H vs SNN Comparison
H vs SNN Comparison
Compare H & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- H
- SNN
- Stock Information
- Founded
- H 1957
- SNN 1856
- Country
- H United States
- SNN United Kingdom
- Employees
- H N/A
- SNN N/A
- Industry
- H Hotels/Resorts
- SNN Industrial Specialties
- Sector
- H Consumer Discretionary
- SNN Health Care
- Exchange
- H Nasdaq
- SNN Nasdaq
- Market Cap
- H 14.0B
- SNN 13.2B
- IPO Year
- H 2009
- SNN 1999
- Fundamental
- Price
- H $148.49
- SNN $31.67
- Analyst Decision
- H Buy
- SNN Hold
- Analyst Count
- H 18
- SNN 3
- Target Price
- H $150.39
- SNN $27.50
- AVG Volume (30 Days)
- H 974.0K
- SNN 1.1M
- Earning Date
- H 08-07-2025
- SNN 08-08-2025
- Dividend Yield
- H 0.40%
- SNN 2.27%
- EPS Growth
- H 23.10
- SNN 56.15
- EPS
- H 7.89
- SNN 0.47
- Revenue
- H $3,216,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- H $113.08
- SNN $6.87
- Revenue Next Year
- H $4.90
- SNN $5.19
- P/E Ratio
- H $18.87
- SNN $33.49
- Revenue Growth
- H N/A
- SNN 4.70
- 52 Week Low
- H $102.43
- SNN $23.69
- 52 Week High
- H $168.20
- SNN $31.84
- Technical
- Relative Strength Index (RSI)
- H 61.02
- SNN 64.11
- Support Level
- H $144.24
- SNN $29.27
- Resistance Level
- H $149.99
- SNN $31.84
- Average True Range (ATR)
- H 2.82
- SNN 0.45
- MACD
- H -0.67
- SNN 0.14
- Stochastic Oscillator
- H 52.21
- SNN 93.39
About H Hyatt Hotels Corporation
Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.